The objective was to study the influence of storage conditions on the quality of inhalation capsules and to investigate patients' knowledge and adherence to storage instructions. Inhalation capsules marketed in the Netherlands were stored at normal (20°C/60% relative humidity) and dry (20°C/25% relative humidity) conditions during 34 days and checked for brittleness. After 1 day of storage at normal conditions, no brittleness was perceived. Longer periods and dry conditions increased the risk of brittleness. Only tiotropium capsules resisted all test situations. Subsequently, patients using inhalation capsules were sent a questionnaire in order to investigate their knowledge and actual behavior regarding storage of the capsules. Adherence to the required storage instructions was achieved by only 31.8% of all patients. Inferior storage locations turned out to be the main problem, 58.7% of the patients applied an incorrect place. Knowledge of the required storage instructions was lacking in 83.6% of all patients. It is concluded that the majority of patients store their inhalation capsules incorrectly and have insufficient knowledge of the appropriate storage conditions. Incorrectly stored capsules may become brittle and cause splintering during inhalation. The feeling of splinters in the mouth/throat may reduce the patient's confidence in the product's quality and affect compliance.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/0897190010372807 | DOI Listing |
Anal Biochem
January 2025
Pharmaceutical Analytical Chemistry Department, Faculty of pharmacy, Zagazig University, Zagazig 44519, Egypt.
This work represents different spectrophotometric techniques for concurrent quantification of Indacaterol (IND) and Mometasone furoate (MOM); co-formulated inhalation capsules to control asthma symptoms. Direct spectrophotometric (D) approach was applied for IND assay. While, absorption factor (AF), ratio difference (RD), mean centering of the ratio spectra (MC), and continuous wavelet transform (CW) techniques were utilized for MOM quantification.
View Article and Find Full Text PDFPharmaceutics
January 2025
College of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea.
/: Inhaler devices have been developed for the effective delivery of inhaled medications used in the treatment of pulmonary diseases. However, differing operating procedures across the devices can lead to user errors and reduce treatment efficacy, especially when patients use multiple devices simultaneously. To address this, we developed a novel dry powder inhaler (DPI), combining fluticasone propionate (FP), salmeterol xinafoate (SX), and tiotropium bromide (TB) into a single device designed for bioequivalent delivery compared to existing commercial products in an animal model.
View Article and Find Full Text PDFPeerJ
December 2024
Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Background: Limited research exists on the features and management of post-COVID cough. This real-world study investigates outpatients with subacute or chronic post-COVID cough, aiming to delineate characteristics and regimen responses within the population.
Method: We enrolled eligible patients from our outpatient unit between August 2023 and February 2024.
mSphere
December 2024
Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Int Immunopharmacol
January 2025
College of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei 230012, China; Research Center of Integrated Traditional Chinese and Western Medicine, Wannan Medical College, Wuhu 241002, China. Electronic address:
Background: Chronic obstructive pulmonary disease (COPD) is characterized for the persistent inflammation. The brain and muscle arnt-like 1 (BMAL1), as a crucial clock gene, is associated with the expression level of upstream factor hypoxia-inducible factor (HIF)-1α in glycolysis, which may affect the occurrence of inflammatory reactions in COPD. However, the moderation effect of Qibai Pingfei Capsule (QBPF) capsule is still unknown on BMAL1 and HIF-1α/glycolytic pathway.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!